{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:22:18Z","timestamp":1792826538394,"version":"4.5.0"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11427-024-2801-x","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T07:40:33Z","timestamp":1748245233000},"page":"2568-2590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pluripotent stem cell-derived cardiomyocyte transplantation: marching from bench to bedside"],"prefix":"10.1007","volume":"68","author":[{"given":"Yi","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pahlavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-da","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2801_CR1","doi-asserted-by":"publisher","first-page":"101980","DOI":"10.1016\/j.arr.2023.101980","volume":"89","author":"M Ala","year":"2023","unstructured":"Ala, M. (2023). The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy. Ageing Res Rev 89. 101980.","journal-title":"Ageing Res Rev"},{"key":"2801_CR2","doi-asserted-by":"publisher","first-page":"8850","DOI":"10.1073\/pnas.1408233111","volume":"111","author":"SR Ali","year":"2014","unstructured":"Ali, S.R., Hippenmeyer, S., Saadat, L.V., Luo, L., Weissman, I.L., and Ardehali, R. (2014). Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc Natl Acad Sci USA 111. 8850\u20138855.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2801_CR3","doi-asserted-by":"publisher","first-page":"936584","DOI":"10.3389\/fbioe.2022.936584","volume":"10","author":"JH An","year":"2022","unstructured":"An, J.H., Koh, H., Ahn, Y., Kim, J., Han, A.R., Lee, J.Y., Kim, S.U., and Lee, J.H. (2022). Maintenance of hypoimmunogenic features via regulation of endogenous antigen processing and presentation machinery. Front Bioeng Biotechnol 10. 936584.","journal-title":"Front Bioeng Biotechnol"},{"key":"2801_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature11807","volume":"494","author":"R Araki","year":"2013","unstructured":"Araki, R., Uda, M., Hoki, Y., Sunayama, M., Nakamura, M., Ando, S., Sugiura, M., Ideno, H., Shimada, A., Nifuji, A., et al. (2013). Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494. 100\u2013104.","journal-title":"Nature"},{"key":"2801_CR5","first-page":"57","volume":"Biophotonics5","author":"S Awasthi","year":"2012","unstructured":"Awasthi, S., Matthews, D.L., Li, R.A., Chiamvimonvat, N., Lieu, D.K., and Chan, J.W. (2012). Label-free identification and characterization of human pluripotent stem cell-derived cardiomyocytes using second harmonic generation (SHG) microscopy. J Biophotonics 5. 57\u201366.","journal-title":"J"},{"key":"2801_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00009.2023","volume":"104","author":"S Barrere-Lemaire","year":"2024","unstructured":"Barrere-Lemaire, S., Vincent, A., Jorgensen, C., Piot, C., Nargeot, J., and Djouad, F. (2024). Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing. Physiol Rev 104. 659\u2013725.","journal-title":"Physiol Rev"},{"key":"2801_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fmolb.2020.00014","volume":"7","author":"P Beauchamp","year":"2020","unstructured":"Beauchamp, P., Jackson, C.B., Ozhathil, L.C., Agarkova, I., Galindo, C.L., Sawyer, D.B., Suter, T.M., and Zuppinger, C. (2020). 3D co-culture of hiPSC-derived cardiomyocytes with cardiac fibroblasts improves tissue-like features of cardiac spheroids. Front Mol Biosci 7. 14.","journal-title":"Front Mol Biosci"},{"key":"2801_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13287-023-03308-5","volume":"14","author":"ME Bogomiakova","year":"2023","unstructured":"Bogomiakova, M.E., Sekretova, E.K., Anufrieva, K.S., Khabarova, P.O., Kazakova, A. N., Bobrovsky, P.A., Grigoryeva, T.V., Eremeev, A.V., Lebedeva, O.S., Bogomazova, A.N., et al. (2023). iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors. Stem Cell Res Ther 14. 77.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bjp.0707619","volume":"153","author":"M Brito-Martins","year":"2008","unstructured":"Brito-Martins, M., Harding, S.E., and Ali, N.N. (2008). \u03b21-and \u03b22-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br J Pharmacol 153. 751\u2013759.","journal-title":"Br J Pharmacol"},{"key":"2801_CR10","doi-asserted-by":"publisher","first-page":"e18293","DOI":"10.1371\/journal.pone.0018293","volume":"6","author":"PW Burridge","year":"2011","unstructured":"Burridge, P.W., Thompson, S., Millrod, M.A., Weinberg, S., Yuan, X., Peters, A., Mahairaki, V., Koliatsos, V.E., Tung, L., Zambidis, E.T., et al. (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 6. e18293.","journal-title":"PLoS One"},{"key":"2801_CR11","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne, R.A., Rossello, X., Coughlan, J.J., Barbato, E., Berry, C., Chieffo, A., Claeys, M.J., Dan, G.A., Dweck, M.R., Galbraith, M., et al. (2023). 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44. 3720\u20133826.","journal-title":"Eur Heart J"},{"key":"2801_CR12","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/s41596-021-00497-2","volume":"16","author":"G Campostrini","year":"2021","unstructured":"Campostrini, G., Meraviglia, V., Giacomelli, E., van Helden, R.W.J., Yiangou, L., Davis, R.P., Bellin, M., Orlova, V.V., and Mummery, C.L. (2021). Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells. Nat Protoc 16. 2213\u20132256.","journal-title":"Nat Protoc"},{"key":"2801_CR13","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jacc.2007.07.054","volume":"50","author":"O Caspi","year":"2007","unstructured":"Caspi, O., Huber, I., Kehat, I., Habib, M., Arbel, G., Gepstein, A., Yankelson, L., Aronson, D., Beyar, R., and Gepstein, L. (2007). Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50. 1884\u20131893.","journal-title":"J Am Coll Cardiol"},{"key":"2801_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.imlet.2021.06.007","volume":"238","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Yan, G., Ma, Y., Zhong, M., Yang, Y., Guo, J., Wang, C., Han, W., Zhang, L., Xu, S., et al. (2021). Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1\/IRF3-regulated-IFN-\u03b3 production. Immunol Lett 238. 21\u201328.","journal-title":"Immunol Lett"},{"key":"2801_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13287-022-03233-z","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Zhou, Y., Zhou, Z., Fang, Y., Ma, L., Zhang, X., Xiong, J., and Liu, L. (2023). Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity. Stem Cell Res Ther 14. 11.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR16","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.122.061736","volume":"148","author":"YC Cheng","year":"2023","unstructured":"Cheng, Y.C., Hsieh, M.L., Lin, C.J., Chang, C.M.C., Huang, C.Y., Puntney, R., Wu Moy, A., Ting, C.Y., Herr Chan, D.Z., Nicholson, M.W., et al. (2023a). Combined treatment of human induced pluripotent stem cell-derived cardiomyocytes and endothelial cells regenerate the infarcted heart in mice and non-human primates. Circulation 148. 1395\u20131409.","journal-title":"Circulation"},{"key":"2801_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11886-023-01857-y","volume":"25","author":"YY Cheng","year":"2023","unstructured":"Cheng, Y.Y., Hu, Y.F., and Hsieh, P.C.H. (2023b). The role of large animal models in cardiac regeneration research using human pluripotent stem cell-derived cardiomyocytes. Curr Cardiol Rep 25. 325\u2013331.","journal-title":"Curr Cardiol Rep"},{"key":"2801_CR18","doi-asserted-by":"publisher","first-page":"111423","DOI":"10.1016\/j.celrep.2022.111423","volume":"40","author":"R Chimienti","year":"2022","unstructured":"Chimienti, R., Baccega, T., Torchio, S., Manenti, F., Pellegrini, S., Cospito, A., Amabile, A., Lombardo, M.T., Monti, P., Sordi, V., et al. (2022). Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-\/- iPSCs for \u03b2 cell replacement. Cell Rep 40. 111423.","journal-title":"Cell Rep"},{"key":"2801_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s13287-022-03209-z","volume":"13","author":"N Chirico","year":"2022","unstructured":"Chirico, N., Kessler, E.L., Maas, R.G.C., Fang, J., Qin, J., Dokter, I., Daniels, M., \u0160ari\u0107, T., Neef, K., Buikema, J.W., et al. (2022). Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 13. 531.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR20","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.7150\/thno.67661","volume":"12","author":"J Cho","year":"2022","unstructured":"Cho, J., Lee, H., Rah, W., Chang, H.J., and Yoon, Y. (2022). From engineered heart tissue to cardiac organoid. Theranostics 12. 2758\u20132772.","journal-title":"Theranostics"},{"key":"2801_CR21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3727\/096368915X689442","volume":"25","author":"EW Choi","year":"2016","unstructured":"Choi, E.W., Lee, H.W., Shin, I.S., Park, J.H., Yun, T.W., Youn, H.Y., and Kim, S.J. (2016). Comparative efficacies of long-term serial transplantation of syngeneic, allogeneic, xenogeneic, or CTLA4Ig-overproducing xenogeneic adipose tissue-derived mesenchymal stem cells on murine systemic lupus erythematosus. Cell Transplant 25. 1193\u20131206.","journal-title":"Cell Transplant"},{"key":"2801_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature13233","volume":"510","author":"JJH Chong","year":"2014","unstructured":"Chong, J.J.H., Yang, X., Don, C.W., Minami, E., Liu, Y.W., Weyers, J.J., Mahoney, W. M., van Biber, B., Cook, S.M., Palpant, N.J., et al. (2014). Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510. 273\u2013277.","journal-title":"Nature"},{"key":"2801_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/14712598.2023.2245329","volume":"23","author":"D Clavellina","year":"2023","unstructured":"Clavellina, D., Balkan, W., and Hare, J.M. (2023). Stem cell therapy for acute myocardial infarction: mesenchymal stem cells and induced pluripotent stem cells. Expert Opin Biol Ther 23. 951\u2013967.","journal-title":"Expert Opin Biol Ther"},{"key":"2801_CR24","doi-asserted-by":"publisher","first-page":"101045","DOI":"10.1016\/j.jocmr.2024.101045","volume":"26","author":"MP Cook","year":"2024","unstructured":"Cook, M.P., Dhahri, W., Laflamme, M.A., Ghugre, N.R., and Wright, G.A. (2024). Using diffusion tensor imaging to depict myocardial changes after matured pluripotent stem cell-derived cardiomyocyte transplantation. J Cardiovasc Magn Reson 26. 101045.","journal-title":"J Cardiovasc Magn Reson"},{"key":"2801_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bbrc.2020.09.021","volume":"533","author":"T Crestani","year":"2020","unstructured":"Crestani, T., Steichen, C., Neri, E., Rodrigues, M., Fonseca-Alaniz, M.H., Ormrod, B., Holt, M.R., Pandey, P., Harding, S., Ehler, E., et al. (2020). Electrical stimulation applied during differentiation drives the hiPSC-CMs towards a mature cardiac conduction-like cells. Biochem Biophys Res Commun 533. 376\u2013382.","journal-title":"Biochem Biophys Res Commun"},{"key":"2801_CR26","doi-asserted-by":"publisher","first-page":"eabb5067","DOI":"10.1126\/sciadv.abb5067","volume":"6","author":"H Cui","year":"2020","unstructured":"Cui, H., Liu, C., Esworthy, T., Huang, Y., Yu, Z., Zhou, X., San, H., Lee, S., Hann, S.Y., Boehm, M., et al. (2020). 4D physiologically adaptable cardiac patch: a 4-month in vivo study for the treatment of myocardial infarction. Sci Adv 6. eabb5067.","journal-title":"Sci Adv"},{"key":"2801_CR27","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.3390\/ijms23137318","volume":"23","author":"FF Darche","year":"2022","unstructured":"Darche, F.F., Ullrich, N.D., Huang, Z., Koenen, M., Rivinius, R., Frey, N., and Schweizer, P.A. (2022). Improved generation of human induced pluripotent stem cell-derived cardiac pacemaker cells using novel differentiation protocols. Int J Mol Sci 23. 7318.","journal-title":"Int J Mol Sci"},{"key":"2801_CR28","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1038\/ncomms4903","volume":"5","author":"PE de Almeida","year":"2014","unstructured":"de Almeida, P.E., Meyer, E.H., Kooreman, N.G., Diecke, S., Dey, D., Sanchez-Freire, V., Hu, S., Ebert, A., Odegaard, J., Mordwinkin, N.M., et al. (2014). Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat Commun 5. 3903.","journal-title":"Nat Commun"},{"key":"2801_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W.O., Wahl, A., Garcia, J.V., Reichenspurner, H., et al. (2019). Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat Biotechnol 37. 252\u2013258.","journal-title":"Nat Biotechnol"},{"key":"2801_CR30","doi-asserted-by":"publisher","first-page":"e2022091118","DOI":"10.1073\/pnas.2022091118","volume":"118","author":"T Deuse","year":"2021","unstructured":"Deuse, T., Tediashvili, G., Hu, X., Gravina, A., Tamenang, A., Wang, D., Connolly, A., Mueller, C., Mallavia, B., Looney, M.R., et al. (2021). Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice. Proc Natl Acad Sci USA 118. e2022091118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2801_CR31","doi-asserted-by":"publisher","first-page":"eaah5457","DOI":"10.1126\/scitranslmed.aah5457","volume":"10","author":"HD Devalla","year":"2018","unstructured":"Devalla, H.D., and Passier, R. (2018). Cardiac differentiation of pluripotent stem cells and implications for modeling the heart in health and disease. Sci Transl Med 10. eaah5457.","journal-title":"Sci Transl Med"},{"key":"2801_CR32","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.121.053563","volume":"145","author":"W Dhahri","year":"2022","unstructured":"Dhahri, W., Sadikov Valdman, T., Wilkinson, D., Pereira, E., Ceylan, E., Andharia, N., Qiang, B., Masoudpour, H., Wulkan, F., Quesnel, E., et al. (2022). In vitro matured human pluripotent stem cell-derived cardiomyocytes form grafts with enhanced structure and function in injured hearts. Circulation 145. 1412\u20131426.","journal-title":"Circulation"},{"key":"2801_CR33","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.2147\/IJN.S269069","volume":"15","author":"J Dong","year":"2020","unstructured":"Dong, J., Wu, Y., Zhang, Y., Yu, M., and Tian, W. (2020). Comparison of the therapeutic effect of allogeneic and xenogeneic small extracellular vesicles in soft tissue repair. Int J Nanomed Volume 15. 6975\u20136991.","journal-title":"Int J Nanomed Volume"},{"key":"2801_CR34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41587-021-00815-9","volume":"39","author":"L Drakhlis","year":"2021","unstructured":"Drakhlis, L., Biswanath, S., Farr, C.M., Lupanow, V., Teske, J., Ritzenhoff, K., Franke, A., Manstein, F., Bolesani, E., Kempf, H., et al. (2021). Human heart-forming organoids recapitulate early heart and foregut development. Nat Biotechnol 39. 737\u2013746.","journal-title":"Nat Biotechnol"},{"key":"2801_CR35","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41581-022-00600-0","volume":"18","author":"C Duneton","year":"2022","unstructured":"Duneton, C., Winterberg, P.D., and Ford, M.L. (2022). Activation and regulation of alloreactive T cell immunity in solid organ transplantation. Nat Rev Nephrol 18. 663\u2013676.","journal-title":"Nat Rev Nephrol"},{"key":"2801_CR36","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1038\/s41598-023-29419-w","volume":"13","author":"L Dvinskikh","year":"2023","unstructured":"Dvinskikh, L., Sparks, H., Brito, L., MacLeod, K.T., Harding, S.E., and Dunsby, C. (2023). Remote-refocusing light-sheet fluorescence microscopy enables 3D imaging of electromechanical coupling of hiPSC-derived and adult cardiomyocytes in co-culture. Sci Rep 13. 3342.","journal-title":"Sci Rep"},{"key":"2801_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/bioengineering10050587","volume":"10","author":"KD Dwyer","year":"2023","unstructured":"Dwyer, K.D., Kant, R.J., Soepriatna, A.H., Roser, S.M., Daley, M.C., Sabe, S.A., Xu, C. M., Choi, B.R., Sellke, F.W., and Coulombe, K.L.K. (2023). One billion hiPSC-cardiomyocytes: upscaling engineered cardiac tissues to create high cell density therapies for clinical translation in heart regeneration. Bioengineering 10. 587.","journal-title":"Bioengineering"},{"key":"2801_CR38","doi-asserted-by":"publisher","first-page":"10312","DOI":"10.1038\/ncomms10312","volume":"7","author":"G Eng","year":"2016","unstructured":"Eng, G., Lee, B.W., Protas, L., Gagliardi, M., Brown, K., Kass, R.S., Keller, G., Robinson, R.B., and Vunjak-Novakovic, G. (2016). Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes. Nat Commun 7. 10312.","journal-title":"Nat Commun"},{"key":"2801_CR39","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3727\/000000004783983594","volume":"13","author":"G Erdag","year":"2004","unstructured":"Erdag, G., and Morgan, J.R. (2004). Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts. Cell Transplant 13. 701\u2013712.","journal-title":"Cell Transplant"},{"key":"2801_CR40","doi-asserted-by":"publisher","first-page":"986107","DOI":"10.3389\/fcell.2022.986107","volume":"10","author":"P Ernst","year":"2023","unstructured":"Ernst, P., Bidwell, P.A., Dora, M., Thomas, D.D., and Kamdar, F. (2023). Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: implications for disease modeling and maturation. Front Cell Dev Biol 10. 986107.","journal-title":"Front Cell Dev Biol"},{"key":"2801_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s11427-023-2500-9","volume":"67","author":"M Fang","year":"2024","unstructured":"Fang, M., Yang, Y.G., and Hu, Z. (2024). Current status and challenges of pig-to-human organ xenotransplantation. Sci China Life Sci 67. 829\u2013831.","journal-title":"Sci China Life Sci"},{"key":"2801_CR42","doi-asserted-by":"publisher","first-page":"2301186","DOI":"10.1002\/adhm.202301186","volume":"12","author":"Y Fang","year":"2023","unstructured":"Fang, Y., Wang, S.P.H., Liao, I., Tsai, K., Huang, P., Yang, P., Yen, C., Liu, P., Shan, Y., and Liu, Y. (2023). HLA-E high\/HLA-G high\/HLA-II low human iPSC-derived cardiomyocytes exhibit low immunogenicity for heart regeneration. Adv Healthc Mater 12. 2301186.","journal-title":"Adv Healthc Mater"},{"key":"2801_CR43","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3390\/ijms21072359","volume":"21","author":"YH Fang","year":"2020","unstructured":"Fang, Y.H., Wang, S.P.H., Gao, Z.H., Wu, S.N., Chang, H.Y., Yang, P.J., Liu, P.Y., and Liu, Y.W. (2020). Efficient cardiac differentiation of human amniotic fluid-derived stem cells into induced pluripotent stem cells and their potential immune privilege. Int J Mol Sci 21. 2359.","journal-title":"Int J Mol Sci"},{"key":"2801_CR44","doi-asserted-by":"publisher","first-page":"19111","DOI":"10.1038\/srep19111","volume":"6","author":"S Funakoshi","year":"2016","unstructured":"Funakoshi, S., Miki, K., Takaki, T., Okubo, C., Hatani, T., Chonabayashi, K., Nishikawa, M., Takei, I., Oishi, A., Narita, M., et al. (2016). Enhanced engraftment, proliferation and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep 6. 19111.","journal-title":"Sci Rep"},{"key":"2801_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13287-020-01752-1","volume":"11","author":"C Gao","year":"2020","unstructured":"Gao, C., Wang, X., Lu, J., Li, Z., Jia, H., Chen, M., Chang, Y., Liu, Y., Li, P., Zhang, B., et al. (2020). Mesenchymal stem cells transfected with sFgl2 inhibit the acute rejection of heart transplantation in mice by regulating macrophage activation. Stem Cell Res Ther 11. 241.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR46","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.117.030785","volume":"137","author":"L Gao","year":"2018","unstructured":"Gao, L., Gregorich, Z.R., Zhu, W., Mattapally, S., Oduk, Y., Lou, X., Kannappan, R., Borovjagin, A.V., Walcott, G.P., Pollard, A.E., et al. (2018). Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation 137. 1712\u20131730.","journal-title":"Circulation"},{"key":"2801_CR47","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/CIRCRESAHA.116.310277","volume":"120","author":"L Gao","year":"2017","unstructured":"Gao, L., Kupfer, M.E., Jung, J.P., Yang, L., Zhang, P., Da Sie, Y., Tran, Q., Ajeti, V., Freeman, B.T., Fast, V.G., et al. (2017). Myocardial tissue engineering with cells derived from human-induced pluripotent stem cells and a native-like, high-resolution, 3-dimensionally printed scaffold. Circ Res 120. 1318\u20131325.","journal-title":"Circ Res"},{"key":"2801_CR48","doi-asserted-by":"publisher","first-page":"1058763","DOI":"10.3389\/fimmu.2022.1058763","volume":"13","author":"LH Gaykema","year":"2023","unstructured":"Gaykema, L.H., van Nieuwland, R.Y., Dekkers, M.C., van Essen, M.F., Heidt, S., Zaldumbide, A., van den Berg, C.W., Rabelink, T.J., and van Kooten, C. (2023). Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids. Front Immunol 13. 1058763.","journal-title":"Front Immunol"},{"key":"2801_CR49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/BF02726779","volume":"57","author":"K George","year":"1990","unstructured":"George, K., Victor, S., and Abel, R. (1990). Reliability of mother as an informant with regard to immunisation. Ind J Pediatr 57. 588\u2013590.","journal-title":"Ind J Pediatr"},{"key":"2801_CR50","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1113\/JP284244","volume":"601","author":"CE Gibbs","year":"2023","unstructured":"Gibbs, C.E., Marchian\u00f3, S., Zhang, K., Yang, X., Murry, C.E., and Boyle, P.M. (2023). Graft-host coupling changes can lead to engraftment arrhythmia: a computational study. J Physiol 601. 2733\u20132749.","journal-title":"J Physiol"},{"key":"2801_CR51","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI200524408","volume":"115","author":"FJ Giordano","year":"2005","unstructured":"Giordano, F.J. (2005). Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115. 500\u2013508.","journal-title":"J Clin Invest"},{"key":"2801_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.semcdb.2021.05.022","volume":"118","author":"MJ Gomez-Garcia","year":"2021","unstructured":"Gomez-Garcia, M.J., Quesnel, E., Al-attar, R., Laskary, A.R., and Laflamme, M.A. (2021). Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo. Semin Cell Dev Biol 118. 163\u2013171.","journal-title":"Semin Cell Dev Biol"},{"key":"2801_CR53","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse, G.G., Hirata, R.K., Funk, S.E., Riolobos, L., Lopes, V.S., Manske, G., Prunkard, D., Colunga, A.G., Hanafi, L.A., Clegg, D.O., et al. (2017). HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol 35. 765\u2013772.","journal-title":"Nat Biotechnol"},{"key":"2801_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ajog.2003.07.022","volume":"190","author":"C G\u00f6therstr\u00f6m","year":"2004","unstructured":"G\u00f6therstr\u00f6m, C., Ringd\u00e9n, O., Tammik, C., Zetterberg, E., Westgren, M., and Le Blanc, K. (2004). Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190. 239\u2013245.","journal-title":"Am J Obstet Gynecol"},{"key":"2801_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.10.001","volume":"183","author":"B Goversen","year":"2018","unstructured":"Goversen, B., van der Heyden, M.A.G., van Veen, T.A.B., and de Boer, T.P. (2018). The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: special focus on I K1. Pharmacol Ther 183. 127\u2013136.","journal-title":"Pharmacol Ther"},{"key":"2801_CR56","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1472-6483(10)60663-3","volume":"13","author":"KH Grinnemo","year":"2006","unstructured":"Grinnemo, K.H., Kumagai-Braesch, M., M\u00e2nsson-Broberg, A., Skottman, H., Hao, X., Siddiqui, A., Andersson, A., Str\u00f6mberg, A.M., Lahesmaa, R., Hovatta, O., et al. (2006). Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 13. 712\u2013724.","journal-title":"Reprod Biomed Online"},{"key":"2801_CR57","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3389\/fimmu.2017.00870","volume":"8","author":"C Gr\u00f6schel","year":"2017","unstructured":"Gr\u00f6schel, C., H\u00fcbscher, D., Nolte, J., Monecke, S., Sasse, A., Elsner, L., Paulus, W., Trenkwalder, C., Poli\u0107, B., Mansouri, A., et al. (2017). Efficient killing of murine pluripotent stem cells by natural killer (NK) cells requires activation by cytokines and partly depends on the activating NK receptor NKG2D. Front Immunol 8. 870.","journal-title":"Front Immunol"},{"key":"2801_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13287-020-01602-0","volume":"11","author":"X Guan","year":"2020","unstructured":"Guan, X., Xu, W., Zhang, H., Wang, Q., Yu, J., Zhang, R., Chen, Y., Xia, Y., Wang, J., and Wang, D. (2020). Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts. Stem Cell Res Ther 11. 73.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR59","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/TP.0b013e318277e378","volume":"95","author":"S Guethoff","year":"2013","unstructured":"Guethoff, S., Meiser, B.M., Groetzner, J., Eifert, S., Grinninger, C., Ueberfuhr, P., Reichart, B., Hagl, C., and Kaczmarek, I. (2013). Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine A in combination with mycophenolate mofetil after heart transplantation. Transplantation 95. 629\u2013634.","journal-title":"Transplantation"},{"key":"2801_CR60","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.healun.2014.11.025","volume":"34","author":"S Guethoff","year":"2015","unstructured":"Guethoff, S., Stroeh, K., Grinninger, C., Koenig, M.A., Kleinert, E.C., Rieger, A., Mayr, T., von Ziegler, F., Reichart, B., Hagl, C., et al. (2015). De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation\u20148-year results. J Heart Lung Transplant 34. 634\u2013642.","journal-title":"J Heart Lung Transplant"},{"key":"2801_CR61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.stem.2013.01.006","volume":"12","author":"P Guha","year":"2013","unstructured":"Guha, P., Morgan, J.W., Mostoslavsky, G., Rodrigues, N.P., and Boyd, A.S. (2013). Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12. 407\u2013412.","journal-title":"Cell Stem Cell"},{"key":"2801_CR62","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/eji.202049107","volume":"51","author":"Y Guo","year":"2021","unstructured":"Guo, Y., Xu, B., Wu, Z., Bo, J., Tong, C., Chen, D., Wang, J., Wang, H., Wang, Y., and Han, W. (2021). Mutant B2M-HLA-E and B2M-HLA-G fusion proteins protects universal chimeric antigen receptor-modified T cells from allogeneic NK cell-mediated lysis. Eur J Immunol 51. 2513\u20132521.","journal-title":"Eur J Immunol"},{"key":"2801_CR63","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/stem.471","volume":"28","author":"I Gutierrez-Aranda","year":"2010","unstructured":"Gutierrez-Aranda, I., Ramos-Mejia, V., Bueno, C., Munoz-Lopez, M., Real, P.J., M\u00e1cia, A., Sanchez, L., Ligero, G., Garcia-Parez, J.L., and Menendez, P. (2010). Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 28. 1568\u20131570.","journal-title":"Stem Cells"},{"key":"2801_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12967-015-0406-3","volume":"13","author":"M Guti\u00e9rrez-Fern\u00e1ndez","year":"2015","unstructured":"Guti\u00e9rrez-Fern\u00e1ndez, M., Rodr\u00edguez-Frutos, B., Ramos-Cejudo, J., Otero-Ortega, L., Fuentes, B., Vallejo-Cremades, M., Sanz-Cuesta, B., and D\u00edez-Tejedor, E. (2015). Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct: proof of concept in rats. J Transl Med 13. 46.","journal-title":"J Transl Med"},{"key":"2801_CR65","doi-asserted-by":"publisher","first-page":"10441","DOI":"10.1073\/pnas.1902566116","volume":"116","author":"X Han","year":"2019","unstructured":"Han, X., Wang, M., Duan, S., Franco, P.J., Kenty, J.H.R., Hedrick, P., Xia, Y., Allen, A., Ferreira, L.M.R., Strominger, J.L., et al. (2019). Generation of hypoimmunogenic human pluripotent stem cells. Proc Natl Acad Sci USA 116. 10441\u201310446.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2801_CR66","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s44161-022-00083-z","volume":"1","author":"G Hansmann","year":"2022","unstructured":"Hansmann, G., Chouvarine, P., Diekmann, F., Giera, M., Ralser, M., M\u00fclleder, M., von Kaisenberg, C., Bertram, H., Legchenko, E., and Hass, R. (2022). Human umbilical cord mesenchymal stem cell-derived treatment of severe pulmonary arterial hypertension. Nat Cardiovasc Res 1. 568\u2013576.","journal-title":"Nat Cardiovasc Res"},{"key":"2801_CR67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nmeth.1403","volume":"7","author":"F Hattori","year":"2010","unstructured":"Hattori, F., Chen, H., Yamashita, H., Tohyama, S., Satoh, Y., Yuasa, S., Li, W., Yamakawa, H., Tanaka, T., Onitsuka, T., et al. (2010). Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 7. 61\u201366.","journal-title":"Nat Methods"},{"key":"2801_CR68","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","volume":"184","author":"P Hofbauer","year":"2021","unstructured":"Hofbauer, P., Jahnel, S.M., Papai, N., Giesshammer, M., Deyett, A., Schmidt, C., Penc, M., Tavernini, K., Grdseloff, N., Meledeth, C., et al. (2021). Cardioids reveal self-organizing principles of human cardiogenesis. Cell 184. 3299\u20133317.e22.","journal-title":"Cell"},{"key":"2801_CR69","doi-asserted-by":"publisher","first-page":"1155052","DOI":"10.3389\/fbioe.2023.1155052","volume":"11","author":"Y Hong","year":"2023","unstructured":"Hong, Y., Zhao, Y., Li, H., Yang, Y., Chen, M., Wang, X., Luo, M., and Wang, K. (2023). Engineering the maturation of stem cell-derived cardiomyocytes. Front Bioeng Biotechnol 11. 1155052.","journal-title":"Front Bioeng Biotechnol"},{"key":"2801_CR70","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13287-022-02834-y","volume":"13","author":"X Hou","year":"2022","unstructured":"Hou, X., Ma, S., Fan, W., Li, F., Xu, M., Yang, C., Liu, F., Yan, Y., Wan, J., Lan, F., et al. (2022). Chemically defined and small molecules-based generation of sinoatrial node-like cells. Stem Cell Res Ther 13. 158.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR71","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/CIRCRESAHA.118.313249","volume":"123","author":"D Hu","year":"2018","unstructured":"Hu, D., Linders, A., Yamak, A., Correia, C., Kijlstra, J.D., Garakani, A., Xiao, L., Milan, D.J., van der Meer, P., Serra, M., et al. (2018). Metabolic maturation of human pluripotent stem cell-derived cardiomyocytes by inhibition of HIF1\u03b1 and LDHA. Circ Res 123. 1066\u20131079.","journal-title":"Circ Res"},{"key":"2801_CR72","doi-asserted-by":"publisher","first-page":"eadg5794","DOI":"10.1126\/scitranslmed.adg5794","volume":"15","author":"X Hu","year":"2023","unstructured":"Hu, X., Gattis, C., Olroyd, A.G., Friera, A.M., White, K., Young, C., Basco, R., Lamba, M., Wells, F., Ankala, R., et al. (2023). Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice. Sci Transl Med 15. eadg5794.","journal-title":"Sci Transl Med"},{"key":"2801_CR73","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41587-023-01784-x","volume":"42","author":"X Hu","year":"2024","unstructured":"Hu, X., White, K., Olroyd, A.G., DeJesus, R., Dominguez, A.A., Dowdle, W.E., Friera, A. M., Young, C., Wells, F., Chu, E.Y., et al. (2024). Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques. Nat Biotechnol 42. 413\u2013423.","journal-title":"Nat Biotechnol"},{"key":"2801_CR74","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1161\/01.RES.69.5.1409","volume":"69","author":"NM Hunkeler","year":"1991","unstructured":"Hunkeler, N.M., Kullman, J., and Murphy, A.M. (1991). Troponin I isoform expression in human heart. Circ Res 69. 1409\u20131414.","journal-title":"Circ Res"},{"key":"2801_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.yjmcc.2015.05.003","volume":"85","author":"HS Hwang","year":"2015","unstructured":"Hwang, H.S., Kryshtal, D.O., Feaster, T.K., Sanchez-Freire, V., Zhang, J., Kamp, T.J., Hong, C.C., Wu, J.C., and Knollmann, B.C. (2015). Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories. J Mol Cell Cardiol 85. 79\u201388.","journal-title":"J Mol Cell Cardiol"},{"key":"2801_CR76","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.3390\/ijms21093052","volume":"21","author":"JW Hwang","year":"2020","unstructured":"Hwang, J.W., Lee, N.K., Yang, J.H., Son, H.J., Bang, S.I., Chang, J.W., and Na, D.L. (2020). A comparison of immune responses exerted following syngeneic, allogeneic, and xenogeneic transplantation of mesenchymal stem cells into the mouse brain. Int J Mol Sci 21. 3052.","journal-title":"Int J Mol Sci"},{"key":"2801_CR77","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/TP.0000000000002384","volume":"103","author":"M Ishida","year":"2019","unstructured":"Ishida, M., Miyagawa, S., Saito, A., Fukushima, S., Harada, A., Ito, E., Ohashi, F., Watabe, T., Hatazawa, J., Matsuura, K., et al. (2019). Transplantation of human-induced pluripotent stem cell-derived cardiomyocytes is superior to somatic stem cell therapy for restoring cardiac function and oxygen consumption in a porcine model of myocardial infarction. Transplantation 103. 291\u2013298.","journal-title":"Transplantation"},{"key":"2801_CR78","doi-asserted-by":"publisher","first-page":"096368972199206","DOI":"10.1177\/0963689721992066","volume":"30","author":"H Ishigaki","year":"2021","unstructured":"Ishigaki, H., Pham, V.L., Terai, J., Sasamura, T., Nguyen, C.T., Ishida, H., Okahara, J., Kaneko, S., Shiina, T., Nakayama, M., et al. (2021). No tumorigenicity of allogeneic induced pluripotent stem cells in major histocompatibility complex-matched cynomolgus macaques. Cell Transplant 30. 0963689721992066.","journal-title":"Cell Transplant"},{"key":"2801_CR79","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.stemcr.2017.02.003","volume":"8","author":"G Itakura","year":"2017","unstructured":"Itakura, G., Kawabata, S., Ando, M., Nishiyama, Y., Sugai, K., Ozaki, M., Iida, T., Ookubo, T., Kojima, K., Kashiwagi, R., et al. (2017). Fail-safe system against potential tumorigenicity after transplantation of iPSC derivatives. Stem Cell Rep 8. 673\u2013684.","journal-title":"Stem Cell Rep"},{"key":"2801_CR80","doi-asserted-by":"publisher","first-page":"10530","DOI":"10.1038\/s41598-023-37235-5","volume":"13","author":"E Ito","year":"2023","unstructured":"Ito, E., Kawamura, A., Kawamura, T., Takeda, M., Harada, A., Mochizuki-Oda, N., Sawa, Y., and Miyagawa, S. (2023). Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model. Sci Rep 13. 10530.","journal-title":"Sci Rep"},{"key":"2801_CR81","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41598-018-38325-5","volume":"9","author":"E Ito","year":"2019","unstructured":"Ito, E., Miyagawa, S., Takeda, M., Kawamura, A., Harada, A., Iseoka, H., Yajima, S., Sougawa, N., Mochizuki-Oda, N., Yasuda, S., et al. (2019). Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application. Sci Rep 9. 1881.","journal-title":"Sci Rep"},{"key":"2801_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0352-x","volume":"51","author":"Y Jang","year":"2019","unstructured":"Jang, Y., Choi, J., Park, N., Kang, J., Kim, M., Kim, Y., and Ju, J.H. (2019). Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering. Exp Mol Med 51. 1\u201311.","journal-title":"Exp Mol Med"},{"key":"2801_CR83","doi-asserted-by":"publisher","first-page":"e13471","DOI":"10.1111\/cpr.13471","volume":"56","author":"T Ji","year":"2023","unstructured":"Ji, T., Niu, S., Fang, M., Xu, L., Wang, X., Zou, J., Xu, F., Zhang, M., Niu, R., Wu, J., et al. (2023). Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies. Cell Prolif 56. e13471.","journal-title":"Cell Prolif"},{"key":"2801_CR84","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.1582-4934.2012.01528.x","volume":"16","author":"J Jiang","year":"2012","unstructured":"Jiang, J., Han, P., Zhang, Q., Zhao, J., Ma, Y., and Mercola, M. (2012). Cardiac differentiation of human pluripotent stem cells. J Cell Mol Med 16. 1663\u20131668.","journal-title":"J Cell Mol Med"},{"key":"2801_CR85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13287-020-02066-y","volume":"12","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., Sun, S.J., Zhen, Z., Wei, R., Zhang, N., Liao, S.Y., and Tse, H.F. (2021). Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction. Stem Cell Res Ther 12. 13.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR86","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1089\/ten.tea.2015.0105","volume":"21","author":"Z Karabekian","year":"2015","unstructured":"Karabekian, Z., Ding, H., Stybayeva, G., Ivanova, I., Muselimyan, N., Haque, A., Toma, I., Posnack, N.G., Revzin, A., Leitenberg, D., et al. (2015). HLA class I depleted hESC as a source of hypoimmunogenic cells for tissue engineering applications. Tissue Eng Part A 21. 2559\u20132571.","journal-title":"Tissue Eng Part A"},{"key":"2801_CR87","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCRESAHA.117.305365","volume":"117","author":"I Karakikes","year":"2015","unstructured":"Karakikes, I., Ameen, M., Termglinchan, V., and Wu, J.C. (2015). Human induced pluripotent stem cell-derived cardiomyocytes. Circ Res 117. 80\u201388.","journal-title":"Circ Res"},{"key":"2801_CR88","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41569-019-0331-x","volume":"17","author":"E Karbassi","year":"2020","unstructured":"Karbassi, E., Fenix, A., Marchiano, S., Muraoka, N., Nakamura, K., Yang, X., and Murry, C.E. (2020). Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat Rev Cardiol 17. 341\u2013359.","journal-title":"Nat Rev Cardiol"},{"key":"2801_CR89","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1097\/TP.0000000000002765","volume":"103","author":"N Kashiyama","year":"2019","unstructured":"Kashiyama, N., Miyagawa, S., Fukushima, S., Kawamura, T., Kawamura, A., Yoshida, S., Eiraku, S., Harada, A., Matsunaga, K., Watabe, T., et al. (2019). MHC-mismatched allotransplantation of induced pluripotent stem cell-derived cardiomyocyte sheets to improve cardiac function in a primate ischemic cardiomyopathy model. Transplantation 103. 1582\u20131590.","journal-title":"Transplantation"},{"key":"2801_CR90","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.stem.2010.12.008","volume":"8","author":"SJ Kattman","year":"2011","unstructured":"Kattman, S.J., Witty, A.D., Gagliardi, M., Dubois, N.C., Niapour, M., Hotta, A., Ellis, J., and Keller, G. (2011). Stage-specific optimization of Activin\/Nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8. 228\u2013240.","journal-title":"Cell Stem Cell"},{"key":"2801_CR91","first-page":"239","volume":"6","author":"S Kawaguchi","year":"2021","unstructured":"Kawaguchi, S., Soma, Y., Nakajima, K., Kanazawa, H., Tohyama, S., Tabei, R., Hirano, A., Handa, N., Yamada, Y., Okuda, S., et al. (2021). Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals. JACC-Basic Transl Sci 6. 239\u2013254.","journal-title":"JACC-Basic Transl Sci"},{"key":"2801_CR92","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1161\/CIRCULATIONAHA.111.084343","volume":"126","author":"M Kawamura","year":"2012","unstructured":"Kawamura, M., Miyagawa, S., Miki, K., Saito, A., Fukushima, S., Higuchi, T., Kawamura, T., Kuratani, T., Daimon, T., Shimizu, T., et al. (2012). Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126. S29\u2013S37.","journal-title":"Circulation"},{"key":"2801_CR93","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.stemcr.2016.01.012","volume":"6","author":"T Kawamura","year":"2016","unstructured":"Kawamura, T., Miyagawa, S., Fukushima, S., Maeda, A., Kashiyama, N., Kawamura, A., Miki, K., Okita, K., Yoshida, Y., Shiina, T., et al. (2016). Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates. Stem Cell Rep 6. 312\u2013320.","journal-title":"Stem Cell Rep"},{"key":"2801_CR94","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1021\/acsbiomaterials.0c00788","volume":"6","author":"P Kc","year":"2020","unstructured":"Kc, P., Shah, M., Shaik, R., Hong, Y., and Zhang, G. (2020). Preseeding of mesenchymal stem cells increases integration of an iPSC-derived CM sheet into a cardiac matrix. ACS Biomater Sci Eng 6. 6808\u20136818.","journal-title":"ACS Biomater Sci Eng"},{"key":"2801_CR95","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI200112131","volume":"108","author":"I Kehat","year":"2001","unstructured":"Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz-Eldor, J., and Gepstein, L. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108. 407\u2013414.","journal-title":"J Clin Invest"},{"key":"2801_CR96","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13287-019-1397-4","volume":"10","author":"MA Khan","year":"2019","unstructured":"Khan, M.A., Alanazi, F., Ahmed, H.A., Shamma, T., Kelly, K., Hammad, M.A., Alawad, A.O., Assiri, A.M., and Broering, D.C. (2019). iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants. Stem Cell Res Ther 10. 290.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR97","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s12015-020-10113-7","volume":"17","author":"A Kim","year":"2021","unstructured":"Kim, A., Lee, K.G., Kwon, Y., Lee, K.I., Yang, H.M., Habib, O., Kim, J., Kim, S.T., Kim, S.J., Kim, J.S., et al. (2021). Off-the-shelf, immune-compatible human embryonic stem cells generated via CRISPR-mediated genome editing. Stem Cell Rev Rep 17. 1053\u20131067.","journal-title":"Stem Cell Rev Rep"},{"key":"2801_CR98","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yjmcc.2015.01.013","volume":"81","author":"JJ Kim","year":"2015","unstructured":"Kim, J.J., Yang, L., Lin, B., Zhu, X., Sun, B., Kaplan, A.D., Bett, G.C.L., Rasmusson, R. L., London, B., and Salama, G. (2015). Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells. J Mol Cell Cardiol 81. 81\u201393.","journal-title":"J Mol Cell Cardiol"},{"key":"2801_CR99","first-page":"50","volume":"19","author":"W Kim","year":"2023","unstructured":"Kim, W., Gwon, Y., Park, S., Kim, H., and Kim, J. (2023). Therapeutic strategies of three-dimensional stem cell spheroids and organoids for tissue repair and regeneration. Bioact Mater 19. 50\u201374.","journal-title":"Bioact Mater"},{"key":"2801_CR100","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1089\/scd.2013.0554","volume":"23","author":"EA Kimbrel","year":"2014","unstructured":"Kimbrel, E.A., Kouris, N.A., Yavanian, G.J., Chu, J., Qin, Y., Chan, A., Singh, R.P., McCurdy, D., Gordon, L., Levinson, R.D., et al. (2014). Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev 23. 1611\u20131624.","journal-title":"Stem Cells Dev"},{"key":"2801_CR101","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.omtm.2022.05.010","volume":"26","author":"Y Kitano","year":"2022","unstructured":"Kitano, Y., Nishimura, S., Kato, T.M., Ueda, A., Takigawa, K., Umekage, M., Nomura, M., Kawakami, A., Ogawa, H., Xu, H., et al. (2022). Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application. Mol Ther-Methods Clin Dev 26. 15\u201325.","journal-title":"Mol Ther-Methods Clin Dev"},{"key":"2801_CR102","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.yjmcc.2022.11.004","volume":"174","author":"H Kobayashi","year":"2023","unstructured":"Kobayashi, H., Tohyama, S., Kanazawa, H., Ichimura, H., Chino, S., Tanaka, Y., Suzuki, Y., Zhao, J., Shiba, N., Kadota, S., et al. (2023). Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration. J Mol Cell Cardiol 174. 77\u201387.","journal-title":"J Mol Cell Cardiol"},{"key":"2801_CR103","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/d41586-024-01453-2","volume":"629","author":"M Kozlov","year":"2024","unstructured":"Kozlov, M. (2024). Pig-organ transplants: What three human recipients have taught scientists. Nature 629. 980\u2013981.","journal-title":"Nature"},{"key":"2801_CR104","doi-asserted-by":"publisher","first-page":"e0125544","DOI":"10.1371\/journal.pone.0125544","volume":"10","author":"V Kruse","year":"2015","unstructured":"Kruse, V., Hamann, C., Monecke, S., Cyganek, L., Elsner, L., Hubscher, D., Walter, L., Streckfuss-Bomeke, K., Guan, K., Dressel, R., et al. (2015). Human induced pluripotent stem cells are targets for allogeneic and autologous natural killer (NK) cells and killing is partly mediated by the activating NK receptor DNAM-1. PLoS One 10. e0125544.","journal-title":"PLoS One"},{"key":"2801_CR105","doi-asserted-by":"publisher","first-page":"026109","DOI":"10.1063\/5.0137458","volume":"7","author":"A Kumar","year":"2023","unstructured":"Kumar, A., He, S., and Mali, P. (2023). Systematic discovery of transcription factors that improve hPSC-derived cardiomyocyte maturation via temporal analysis of bioengineered cardiac tissues. APL Bioeng 7. 026109.","journal-title":"APL Bioeng"},{"key":"2801_CR106","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nbt1117","volume":"23","author":"MA Laflamme","year":"2005","unstructured":"Laflamme, M.A., and Murry, C.E. (2005). Regenerating the heart. Nat Biotechnol 23. 845\u2013856.","journal-title":"Nat Biotechnol"},{"key":"2801_CR107","doi-asserted-by":"publisher","first-page":"1247125","DOI":"10.1126\/science.1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M.A., and Knoblich, J.A. (2014). Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345. 1247125.","journal-title":"Science"},{"key":"2801_CR108","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1038\/s41467-021-25329-5","volume":"12","author":"YR Lewis-Israeli","year":"2021","unstructured":"Lewis-Israeli, Y.R., Wasserman, A.H., Gabalski, M.A., Volmert, B.D., Ming, Y., Ball, K. A., Yang, W., Zou, J., Ni, G., Pajares, N., et al. (2021). Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. Nat Commun 12. 5142.","journal-title":"Nat Commun"},{"key":"2801_CR109","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1002\/mco2.289","volume":"4","author":"H Li","year":"2023","unstructured":"Li, H., Wang, T., Feng, Y., Sun, K., Huang, G., Cao, Y., and Xu, A. (2023). Optimal transplantation strategy using human induced pluripotent stem cell-derived cardiomyocytes for acute myocardial infarction in nonhuman primates. MedComm 4. e289.","journal-title":"MedComm"},{"key":"2801_CR110","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nmeth.3448","volume":"12","author":"X Lian","year":"2015","unstructured":"Lian, X., Bao, X., Zilberter, M., Westman, M., Fisahn, A., Hsiao, C., Hazeltine, L.B., Dunn, K.K., Kamp, T.J., and Palecek, S.P. (2015). Chemically defined, albumin-free human cardiomyocyte generation. Nat Methods 12. 595\u2013596.","journal-title":"Nat Methods"},{"key":"2801_CR111","doi-asserted-by":"publisher","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","volume":"109","author":"X Lian","year":"2012","unstructured":"Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L.B., Azarin, S.M., Raval, K.K., Zhang, J., Kamp, T.J., and Palecek, S.P. (2012). Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 109. E1848\u2013E1857.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2801_CR112","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nprot.2012.150","volume":"8","author":"X Lian","year":"2013","unstructured":"Lian, X., Zhang, J., Azarin, S.M., Zhu, K., Hazeltine, L.B., Bao, X., Hsiao, C., Kamp, T.J., and Palecek, S.P. (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions. Nat Protoc 8. 162\u2013175.","journal-title":"Nat Protoc"},{"key":"2801_CR113","doi-asserted-by":"publisher","first-page":"096368972095414","DOI":"10.1177\/0963689720954140","volume":"29","author":"KC Lin","year":"2020","unstructured":"Lin, K.C., Yeh, J.N., Chen, Y.L., Chiang, J.Y., Sung, P.H., Lee, F.Y., Guo, J., and Yip, H. K. (2020). Xenogeneic and allogeneic mesenchymal stem cells effectively protect the lung against ischemia-reperfusion injury through downregulating the inflammatory, oxidative stress, and autophagic signaling pathways in rat. Cell Transplant 29. 096368972095414.","journal-title":"Cell Transplant"},{"key":"2801_CR114","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.18632\/aging.103088","volume":"12","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Bai, H., Guo, F., Thai, P.N., Luo, X., Zhang, P., Yang, C., Feng, X., Zhu, D., Guo, J., et al. (2020). PGC-1\u03b1 activator ZLN005 promotes maturation of cardiomyocytes derived from human embryonic stem cells. Aging 12. 7411\u20137430.","journal-title":"Aging"},{"key":"2801_CR115","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt.4162","volume":"36","author":"YW Liu","year":"2018","unstructured":"Liu, Y.W., Chen, B., Yang, X., Fugate, J.A., Kalucki, F.A., Futakuchi-Tsuchida, A., Couture, L., Vogel, K.W., Astley, C.A., Baldessari, A., et al. (2018). Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat Biotechnol 36. 597\u2013605.","journal-title":"Nat Biotechnol"},{"key":"2801_CR116","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/FJC.0b013e3181e74a14","volume":"56","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G.D., and Jaswal, J.S. (2010). Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol 56. 130\u2013140.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2801_CR117","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/cvr\/cvad004","volume":"119","author":"X Lou","year":"2023","unstructured":"Lou, X., Tang, Y., Ye, L., Pretorius, D., Fast, V.G., Kahn-Krell, A.M., Zhang, J., Zhang, J., Qiao, A., Qin, G., et al. (2023). Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice. Cardiovasc Res 119. 1062\u20131076.","journal-title":"Cardiovasc Res"},{"key":"2801_CR118","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/cvr\/cvz179","volume":"116","author":"X Lou","year":"2020","unstructured":"Lou, X., Zhao, M., Fan, C., Fast, V.G., Valarmathi, M.T., Zhu, W., and Zhang, J. (2020). N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts. Cardiovasc Res 116. 671\u2013685.","journal-title":"Cardiovasc Res"},{"key":"2801_CR119","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.7150\/thno.54999","volume":"11","author":"K Lu","year":"2021","unstructured":"Lu, K., Seidel, T., Cao-Ehlker, X., Dorn, T., Batcha, A.M.N., Schneider, C.M., Semmler, M., Volk, T., Moretti, A., Dendorfer, A., et al. (2021). Progressive stretch enhances growth and maturation of 3D stem-cell-derived myocardium. Theranostics 11. 6138\u20136153.","journal-title":"Theranostics"},{"key":"2801_CR120","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/d41586-020-01285-w","volume":"581","author":"S Mallapaty","year":"2020","unstructured":"Mallapaty, S. (2020). Revealed: two men in China were first to receive pioneering stem-cell treatment for heart disease. Nature 581. 249\u2013250.","journal-title":"Nature"},{"key":"2801_CR121","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/d41586-024-01613-4","volume":"630","author":"S Mallapaty","year":"2024","unstructured":"Mallapaty, S. (2024). First pig-to-human liver transplant recipient \u2018doing very well\u2019. Nature 630. 18.","journal-title":"Nature"},{"key":"2801_CR122","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai, M., Watanabe, A., Kurimoto, Y., Hirami, Y., Morinaga, C., Daimon, T., Fujihara, M., Akimaru, H., Sakai, N., Shibata, Y., et al. (2017). Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med 376. 1038\u20131046.","journal-title":"N Engl J Med"},{"key":"2801_CR123","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.stem.2023.03.010","volume":"30","author":"S Marchiano","year":"2023","unstructured":"Marchiano, S., Nakamura, K., Reinecke, H., Neidig, L., Lai, M., Kadota, S., Perbellini, F., Yang, X., Klaiman, J.M., Blakely, L.P., et al. (2023). Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy. Cell Stem Cell 30. 396\u2013414.e9.","journal-title":"Cell Stem Cell"},{"key":"2801_CR124","doi-asserted-by":"publisher","first-page":"e010239","DOI":"10.1161\/JAHA.118.010239","volume":"7","author":"S Mattapally","year":"2018","unstructured":"Mattapally, S., Pawlik, K.M., Fast, V.G., Zumaquero, E., Lund, F.E., Randall, T.D., Townes, T.M., and Zhang, J. (2018a). Human leukocyte antigen class I and II knockout human induced pluripotent stem cell-derived cells: universal donor for cell therapy. J Am Heart Assoc 7. e010239.","journal-title":"J Am Heart Assoc"},{"key":"2801_CR125","doi-asserted-by":"publisher","first-page":"H327","DOI":"10.1152\/ajpheart.00688.2017","volume":"315","author":"S Mattapally","year":"2018","unstructured":"Mattapally, S., Zhu, W., Fast, V.G., Gao, L., Worley, C., Kannappan, R., Borovjagin, A. V., and Zhang, J. (2018b). Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice. Am J Physiol-Heart Circul Physiol 315. H327\u2013H339.","journal-title":"Am J Physiol-Heart Circul Physiol"},{"key":"2801_CR126","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","volume":"36","author":"P Menasche","year":"2015","unstructured":"Menasche, P., Vanneaux, V., Hag\u00e8ge, A., Bel, A., Cholley, B., Cacciapuoti, I., Parouchev, A., Benhamouda, N., Tachdjian, G., Tosca, L., et al. (2015). Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur Heart J 36. 2011\u20132017.","journal-title":"Eur Heart J"},{"key":"2801_CR127","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","volume":"71","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9, P., Vanneaux, V., Hag\u00e8ge, A., Bel, A., Cholley, B., Parouchev, A., Cacciapuoti, I., Al-Daccak, R., Benhamouda, N., Blons, H., et al. (2018). Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J Am Coll Cardiol 71. 429\u2013438.","journal-title":"J Am Coll Cardiol"},{"key":"2801_CR128","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jacc.2017.11.042","volume":"71","author":"LW Miller","year":"2018","unstructured":"Miller, L.W. (2018). Trial of embryonic stem cell-derived cardiac progenitor cells. J Am Coll Cardiol 71. 439\u2013442.","journal-title":"J Am Coll Cardiol"},{"key":"2801_CR129","doi-asserted-by":"publisher","first-page":"E8372","DOI":"10.1073\/pnas.1707316114","volume":"114","author":"RJ Mills","year":"2017","unstructured":"Mills, R.J., Titmarsh, D.M., Koenig, X., Parker, B.L., Ryall, J.G., Quaife-Ryan, G.A., Voges, H.K., Hodson, M.P., Ferguson, C., Drowley, L., et al. (2017). Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc Natl Acad Sci USA 114. E8372\u2013E8381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2801_CR130","doi-asserted-by":"publisher","first-page":"e4203","DOI":"10.21769\/BioProtoc.4203","volume":"11","author":"T Miwa","year":"2021","unstructured":"Miwa, T., Idiris, A., and Kumagai, H. (2021). High-throughput 3D spheroid formation and effective cardiomyocyte differentiation from human iPS cells using the microfabric vessels EZSPHERETM. Bio-Protocol 11. e4203.","journal-title":"Bio-Protocol"},{"key":"2801_CR131","doi-asserted-by":"publisher","first-page":"950829","DOI":"10.3389\/fcvm.2022.950829","volume":"9","author":"S Miyagawa","year":"2022","unstructured":"Miyagawa, S., Kainuma, S., Kawamura, T., Suzuki, K., Ito, Y., Iseoka, H., Ito, E., Takeda, M., Sasai, M., Mochizuki-Oda, N., et al. (2022). Case report: transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy. Front Cardiovasc Med 9. 950829.","journal-title":"Front Cardiovasc Med"},{"key":"2801_CR132","doi-asserted-by":"publisher","first-page":"e98319","DOI":"10.1371\/journal.pone.0098319","volume":"9","author":"Y Mizukami","year":"2014","unstructured":"Mizukami, Y., Abe, T., Shibata, H., Makimura, Y., Fujishiro, S., Yanase, K., Hishikawa, S., Kobayashi, E., Hanazono, Y., and Boussiotis, V.A. (2014). MHC-matched induced pluripotent stem cells can attenuate cellular and humoral immune responses but are still susceptible to innate immunity in pigs. PLoS One 9. e98319.","journal-title":"PLoS One"},{"key":"2801_CR133","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa2120238","volume":"386","author":"RA Montgomery","year":"2022","unstructured":"Montgomery, R.A., Stern, J.M., Lonze, B.E., Tatapudi, V.S., Mangiola, M., Wu, M., Weldon, E., Lawson, N., Deterville, C., Dieter, R.A., et al. (2022). Results of two cases of pig-to-human kidney xenotransplantation. N Engl J Med 386. 1889\u20131898.","journal-title":"N Engl J Med"},{"key":"2801_CR134","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","volume":"111","author":"CL Mummery","year":"2012","unstructured":"Mummery, C.L., Zhang, J., Ng, E.S., Elliott, D.A., Elefanty, A.G., and Kamp, T.J. (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes. Circ Res 111. 344\u2013358.","journal-title":"Circ Res"},{"key":"2801_CR135","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1469-7580.2002.00031.x","volume":"200","author":"C Mummery","year":"2002","unstructured":"Mummery, C., Ward, D., Van Den Brink, C.E., Bird, S.D., Doevendans, P.A., Opthof, T., De La Riviere, A.B., Tertoolen, L., Van Der Heyden, M., and Pera, M. (2002). Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anatomy 200. 233\u2013242.","journal-title":"J Anatomy"},{"key":"2801_CR136","doi-asserted-by":"publisher","first-page":"120033","DOI":"10.1016\/j.biomaterials.2020.120033","volume":"251","author":"F Munarin","year":"2020","unstructured":"Munarin, F., Kant, R.J., Rupert, C.E., Khoo, A., and Coulombe, K.L.K. (2020). Engineered human myocardium with local release of angiogenic proteins improves vascularization and cardiac function in injured rat hearts. Biomaterials 251. 120033.","journal-title":"Biomaterials"},{"key":"2801_CR137","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcdb.2021.04.019","volume":"119","author":"SA Murphy","year":"2021","unstructured":"Murphy, S.A., Chen, E.Z., Tung, L., Boheler, K.R., and Kwon, C. (2021). Maturing heart muscle cells: mechanisms and transcriptomic insights. Semin Cell Dev Biol 119. 49\u201360.","journal-title":"Semin Cell Dev Biol"},{"key":"2801_CR138","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.stemcr.2021.08.005","volume":"16","author":"K Nakamura","year":"2021","unstructured":"Nakamura, K., Neidig, L.E., Yang, X., Weber, G.J., El-Nachef, D., Tsuchida, H., Dupras, S., Kalucki, F.A., Jayabalu, A., Futakuchi-Tsuchida, A., et al. (2021). Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes. Stem Cell Rep 16. 2473\u20132487.","journal-title":"Stem Cell Rep"},{"key":"2801_CR139","doi-asserted-by":"publisher","first-page":"10840","DOI":"10.1038\/s41598-019-47134-3","volume":"9","author":"Y Nakamura","year":"2019","unstructured":"Nakamura, Y., Miyagawa, S., Yoshida, S., Sasawatari, S., Toyofuku, T., Toda, K., and Sawa, Y. (2019). Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model. Sci Rep 9. 10840.","journal-title":"Sci Rep"},{"key":"2801_CR140","doi-asserted-by":"publisher","first-page":"794690","DOI":"10.3389\/fcvm.2021.794690","volume":"8","author":"K Neef","year":"2022","unstructured":"Neef, K., Drey, F., Lepperhof, V., Wahlers, T., Hescheler, J., Choi, Y.H., and \u0160ari\u0107, T. (2022). Co-transplantation of mesenchymal stromal cells and induced pluripotent stem cell-derived cardiomyocytes improves cardiac function after myocardial damage. Front Cardiovasc Med 8. 794690.","journal-title":"Front Cardiovasc Med"},{"key":"2801_CR141","doi-asserted-by":"publisher","first-page":"1900344","DOI":"10.1002\/advs.201900344","volume":"6","author":"N Noor","year":"2019","unstructured":"Noor, N., Shapira, A., Edri, R., Gal, I., Wertheim, L., and Dvir, T. (2019). 3D printing of personalized thick and perfusable cardiac patches and hearts. Adv Sci 6. 1900344.","journal-title":"Adv Sci"},{"key":"2801_CR142","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/01.RES.0000124301.48193.E1","volume":"94","author":"CA Opitz","year":"2004","unstructured":"Opitz, C.A., Leake, M.C., Makarenko, I., Benes, V., and Linke, W.A. (2004). Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ Res 94. 967\u2013975.","journal-title":"Circ Res"},{"key":"2801_CR143","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.scr.2010.01.002","volume":"4","author":"TG Otsuji","year":"2010","unstructured":"Otsuji, T.G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M., and Nakatsuji, N. (2010). Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs. Stem Cell Res 4. 201\u2013213.","journal-title":"Stem Cell Res"},{"key":"2801_CR144","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.medj.2024.05.003","volume":"5","author":"W Pan","year":"2024","unstructured":"Pan, W., Zhang, W., Zheng, B., Camellato, B.R., Stern, J., Lin, Z., Khodadadi-Jamayran, A., Kim, J., Sommer, P., Khalil, K., et al. (2024). Cellular dynamics in pig-to-human kidney xenotransplantation. Med 5. 1016\u20131029.e4.","journal-title":"Med"},{"key":"2801_CR145","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/ijms21010089","volume":"21","author":"PR Pandey","year":"2019","unstructured":"Pandey, P.R., Tomney, A., Woon, M.T., Uth, N., Shafighi, F., Ngabo, I., Vallabhaneni, H., Levinson, Y., Abraham, E., and Friedrich Ben-Nun, I. (2019). End-to-end platform for human pluripotent stem cell manufacturing. Int J Mol Sci 21. 89.","journal-title":"Int J Mol Sci"},{"key":"2801_CR146","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/ten.teb.2014.0662","volume":"21","author":"A Parikh","year":"2015","unstructured":"Parikh, A., Wu, J., Blanton, R.M., and Tzanakakis, E.S. (2015). Signaling pathways and gene regulatory networks in cardiomyocyte differentiation. Tissue Eng Part B-Rev 21. 377\u2013392.","journal-title":"Tissue Eng Part B-Rev"},{"key":"2801_CR147","doi-asserted-by":"publisher","first-page":"9995","DOI":"10.3390\/ijms24129995","volume":"24","author":"L Patel","year":"2023","unstructured":"Patel, L., Worch, J.C., Dove, A.P., and Gehmlich, K. (2023). The utilisation of hydrogels for iPSC-cardiomyocyte research. Int J Mol Sci 24. 9995.","journal-title":"Int J Mol Sci"},{"key":"2801_CR148","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","volume":"118","author":"AR Pinto","year":"2016","unstructured":"Pinto, A.R., Ilinykh, A., Ivey, M.J., Kuwabara, J.T., D\u2019Antoni, M.L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N.A., et al. (2016). Revisiting cardiac cellular composition. Circ Res 118. 400\u2013409.","journal-title":"Circ Res"},{"key":"2801_CR149","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.3390\/ijms20153799","volume":"20","author":"JM Pioner","year":"2019","unstructured":"Pioner, J.M., Santini, L., Palandri, C., Martella, D., Lupi, F., Langione, M., Querceto, S., Grandinetti, B., Balducci, V., Benzoni, P., et al. (2019). Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates. Int J Mol Sci 20. 3799.","journal-title":"Int J Mol Sci"},{"key":"2801_CR150","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.120.047904","volume":"143","author":"E Querdel","year":"2021","unstructured":"Querdel, E., Reinsch, M., Castro, L., Kose, D., Bahr, A., Reich, S., Geertz, B., Ulmer, B., Schulze, M., Lemoine, M.D., et al. (2021). Human engineered heart tissue patches remuscularize the injured heart in a dose-dependent manner. Circulation 143. 1991\u20132006.","journal-title":"Circulation"},{"key":"2801_CR151","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-016-2849-0","volume":"424","author":"V Rai","year":"2017","unstructured":"Rai, V., Sharma, P., Agrawal, S., and Agrawal, D.K. (2017). Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research. Mol Cell Biochem 424. 123\u2013145.","journal-title":"Mol Cell Biochem"},{"key":"2801_CR152","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41551-020-0539-4","volume":"4","author":"DJ Richards","year":"2020","unstructured":"Richards, D.J., Li, Y., Kerr, C.M., Yao, J., Beeson, G.C., Coyle, R.C., Chen, X., Jia, J., Damon, B., Wilson, R., et al. (2020). Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity. Nat Biomed Eng 4. 446\u2013462.","journal-title":"Nat Biomed Eng"},{"key":"2801_CR153","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCRESAHA.115.306985","volume":"117","author":"J Riegler","year":"2015","unstructured":"Riegler, J., Tiburcy, M., Ebert, A., Tzatzalos, E., Raaz, U., Abilez, O.J., Shen, Q., Kooreman, N.G., Neofytou, E., Chen, V.C., et al. (2015). Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model. Circ Res 117. 720\u2013730.","journal-title":"Circ Res"},{"key":"2801_CR154","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41586-018-0051-0","volume":"557","author":"NC Rivron","year":"2018","unstructured":"Rivron, N.C., Frias-Aldeguer, J., Vrij, E.J., Boisset, J.C., Korving, J., Vivi\u00e9, J., Truckenm\u00fcller, R.K., van Oudenaarden, A., van Blitterswijk, C.A., and Geijsen, N. (2018). Blastocyst-like structures generated solely from stem cells. Nature 557. 106\u2013111.","journal-title":"Nature"},{"key":"2801_CR155","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/stem.1331","volume":"31","author":"C Robertson","year":"2013","unstructured":"Robertson, C., Tran, D.D., and George, S.C. (2013). Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 31. 829\u2013837.","journal-title":"Stem Cells"},{"key":"2801_CR156","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","volume":"12","author":"R Romagnuolo","year":"2019","unstructured":"Romagnuolo, R., Masoudpour, H., Porta-Sanchez, A., Qiang, B., Barry, J., Laskary, A., Qi, X., Masse, S., Magtibay, K., Kawajiri, H., et al. (2019). Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias. Stem Cell Rep 12. 967\u2013981.","journal-title":"Stem Cell Rep"},{"key":"2801_CR157","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G.A., Mensah, G.A., Johnson, C.O., Addolorato, G., Ammirati, E., Baddour, L.M., Barengo, N.C., Beaton, A.Z., Benjamin, E.J., Benziger, C.P., et al. (2020). Global burden of cardiovascular diseases and risk factors, 1990\u20132019. J Am Coll Cardiol 76. 2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"2801_CR158","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","volume":"134","author":"JL Ruan","year":"2016","unstructured":"Ruan, J.L., Tulloch, N.L., Razumova, M.V., Saiget, M., Muskheli, V., Pabon, L., Reinecke, H., Regnier, M., and Murry, C.E. (2016). Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation 134. 1557\u20131567.","journal-title":"Circulation"},{"key":"2801_CR159","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/scd.2013.0272","volume":"23","author":"M Rubach","year":"2014","unstructured":"Rubach, M., Adelmann, R., Haustein, M., Drey, F., Pfannkuche, K., Xiao, B., Koester, A., Udink ten Cate, F.E.A., Choi, Y.H., Neef, K., et al. (2014). Mesenchymal stem cells and their conditioned medium improve integration of purified induced pluripotent stem cell-derived cardiomyocyte clusters into myocardial tissue. Stem Cells Dev 23. 643\u2013653.","journal-title":"Stem Cells Dev"},{"key":"2801_CR160","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-024-02972-1","volume":"30","author":"E Schmauch","year":"2024","unstructured":"Schmauch, E., Piening, B., Mohebnasab, M., Xia, B., Zhu, C., Stern, J., Zhang, W., Dowdell, A.K., Kim, J.I., Andrijevic, D., et al. (2024). Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat Med 30. 1448\u20131460.","journal-title":"Nat Med"},{"key":"2801_CR161","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer, J.S., Song, B., Herrington, T.M., Park, T.Y., Lee, N., Ko, S., Jeon, J., Cha, Y., Kim, K., Li, Q., et al. (2020). Personalized iPSC-derived dopamine progenitor cells for Parkinson\u2019s disease. N Engl J Med 382. 1926\u20131932.","journal-title":"N Engl J Med"},{"key":"2801_CR162","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fcell.2017.00050","volume":"5","author":"GJ Scuderi","year":"2017","unstructured":"Scuderi, G.J., and Butcher, J. (2017). Naturally engineered maturation of cardiomyocytes. Front Cell Dev Biol 5. 50.","journal-title":"Front Cell Dev Biol"},{"key":"2801_CR163","doi-asserted-by":"publisher","first-page":"718404","DOI":"10.3389\/fphys.2021.718404","volume":"12","author":"IE Setterberg","year":"2021","unstructured":"Setterberg, I.E., Le, C., Frisk, M., Perdreau-Dahl, H., Li, J., and Louch, W.E. (2021). The physiology and pathophysiology of T-tubules in the heart. Front Physiol 12. 718404.","journal-title":"Front Physiol"},{"key":"2801_CR164","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41467-017-01946-x","volume":"8","author":"IY Shadrin","year":"2017","unstructured":"Shadrin, I.Y., Allen, B.W., Qian, Y., Jackman, C.P., Carlson, A.L., Juhas, M.E., and Bursac, N. (2017). Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. Nat Commun 8. 1825.","journal-title":"Nat Commun"},{"key":"2801_CR165","first-page":"1034","volume":"15","author":"Z Shen","year":"1996","unstructured":"Shen, Z., Pelletier, S., Mohiuddin, M., Yokoyama, H., Reiss, G.R., and DiSesa, V.J. (1996). Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens. J Heart Lung Transplant 15. 1034\u20131038.","journal-title":"J Heart Lung Transplant"},{"key":"2801_CR166","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/stem.3269","volume":"38","author":"L Shi","year":"2020","unstructured":"Shi, L., Li, W., Liu, Y., Chen, Z., Hui, Y., Hao, P., Xu, X., Zhang, S., Feng, H., Zhang, B., et al. (2020). Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted \u03b22m-HLA-G fusion proteins. Stem Cells 38. 1423\u20131437.","journal-title":"Stem Cells"},{"key":"2801_CR167","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi, Y., Inoue, H., Wu, J.C., and Yamanaka, S. (2017). Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov 16. 115\u2013130.","journal-title":"Nat Rev Drug Discov"},{"key":"2801_CR168","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature11317","volume":"489","author":"Y Shiba","year":"2012","unstructured":"Shiba, Y., Fernandes, S., Zhu, W.Z., Filice, D., Muskheli, V., Kim, J., Palpant, N.J., Gantz, J., Moyes, K.W., Reinecke, H., et al. (2012). Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489. 322\u2013325.","journal-title":"Nature"},{"key":"2801_CR169","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nature19815","volume":"538","author":"Y Shiba","year":"2016","unstructured":"Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., Ogasawara, T., Okada, K., Shiba, N., Sakamoto, K., et al. (2016). Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538. 388\u2013391.","journal-title":"Nature"},{"key":"2801_CR170","doi-asserted-by":"publisher","first-page":"2302229","DOI":"10.1002\/adma.202302229","volume":"35","author":"E Silberman","year":"2023","unstructured":"Silberman, E., Oved, H., Namestnikov, M., Shapira, A., and Dvir, T. (2023). Post-maturation reinforcement of 3D-printed vascularized cardiac tissues. Adv Mater 35. 2302229.","journal-title":"Adv Mater"},{"key":"2801_CR171","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.trre.2015.02.005","volume":"29","author":"C S\u00f6derlund","year":"2015","unstructured":"S\u00f6derlund, C., and R\u00e5degran, G. (2015). Immunosuppressive therapies after heart transplantation\u2014the balance between under-and over-immunosuppression. Transplant Rev 29. 181\u2013189.","journal-title":"Transplant Rev"},{"key":"2801_CR172","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13287-022-02720-7","volume":"13","author":"C Song","year":"2022","unstructured":"Song, C., Wang, L., Li, Q., Liao, B., Qiao, W., Li, Q., Dong, N., and Li, L. (2022a). Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells. Stem Cell Res Ther 13. 48.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR173","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s13770-021-00427-z","volume":"19","author":"M Song","year":"2022","unstructured":"Song, M., Jang, Y., Kim, S.J., and Park, Y. (2022b). Cyclic stretching induces maturation of human-induced pluripotent stem cell-derived cardiomyocytes through nuclear-mechanotransduction. Tissue Eng Regen Med 19. 781\u2013792.","journal-title":"Tissue Eng Regen Med"},{"key":"2801_CR174","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1161\/CIRCULATIONAHA.113.005841","volume":"129","author":"DE Sosnovik","year":"2014","unstructured":"Sosnovik, D.E., Mekkaoui, C., Huang, S., Chen, H.H., Dai, G., Stoeck, C.T., Ngoy, S., Guan, J., Wang, R., Kostis, W.J., et al. (2014). Microstructural impact of ischemia and bone marrow-derived cell therapy revealed with diffusion tensor magnetic resonance imaging tractography of the heart in vivo. Circulation 129. 1731\u20131741.","journal-title":"Circulation"},{"key":"2801_CR175","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature09691","volume":"470","author":"JR Spence","year":"2011","unstructured":"Spence, J.R., Mayhew, C.N., Rankin, S.A., Kuhar, M.F., Vallance, J.E., Tolle, K., Hoskins, E.E., Kalinichenko, V.V., Wells, S.I., Zorn, A.M., et al. (2011). Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470. 105\u2013109.","journal-title":"Nature"},{"key":"2801_CR176","doi-asserted-by":"publisher","first-page":"1127704","DOI":"10.3389\/fimmu.2023.1127704","volume":"14","author":"M Strzelec","year":"2023","unstructured":"Strzelec, M., Detka, J., Mieszczak, P., Soboci.ska, M.K., and Majka, M. (2023). Immunomodulation.a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. Front Immunol 14. 1127704.","journal-title":"Front Immunol"},{"key":"2801_CR177","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/jcm9072217","volume":"9","author":"S Sugita","year":"2020","unstructured":"Sugita, S., Mandai, M., Hirami, Y., Takagi, S., Maeda, T., Fujihara, M., Matsuzaki, M., Yamamoto, M., Iseki, K., Hayashi, N., et al. (2020). HLA-matched allogeneic iPS cells-derived RPE transplantation for macular degeneration. J Clin Med 9. 2217.","journal-title":"J Clin Med"},{"key":"2801_CR178","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.7150\/thno.46119","volume":"11","author":"SJ Sun","year":"2021","unstructured":"Sun, S.J., Lai, W.H., Jiang, Y., Zhen, Z., Wei, R., Lian, Q., Liao, S.Y., and Tse, H.F. (2021). Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction. Theranostics 11. 1641\u20131654.","journal-title":"Theranostics"},{"key":"2801_CR179","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ymeth.2015.11.005","volume":"101","author":"X Sun","year":"2016","unstructured":"Sun, X., and Nunes, S.S. (2016). Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Methods 101. 21\u201326.","journal-title":"Methods"},{"key":"2801_CR180","doi-asserted-by":"publisher","first-page":"eaax2992","DOI":"10.1126\/scitranslmed.aax2992","volume":"12","author":"X Sun","year":"2020","unstructured":"Sun, X., Wu, J., Qiang, B., Romagnuolo, R., Gagliardi, M., Keller, G., Laflamme, M.A., Li, R., and Nunes, S.S. (2020). Transplanted microvessels improve pluripotent stem cell-derived cardiomyocyte engraftment and cardiac function after infarction in rats. Sci Transl Med 12. eaax2992.","journal-title":"Sci Transl Med"},{"key":"2801_CR181","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.stemcr.2019.11.011","volume":"14","author":"D Suzuki","year":"2020","unstructured":"Suzuki, D., Flahou, C., Yoshikawa, N., Stirblyte, I., Hayashi, Y., Sawaguchi, A., Akasaka, M., Nakamura, S., Higashi, N., Xu, H., et al. (2020). iPSC-derived platelets depleted of HLA class I are inert to anti-HLA class I and natural killer cell immunity. Stem Cell Rep 14. 49\u201359.","journal-title":"Stem Cell Rep"},{"key":"2801_CR182","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.healun.2018.11.002","volume":"38","author":"R Tabei","year":"2019","unstructured":"Tabei, R., Kawaguchi, S., Kanazawa, H., Tohyama, S., Hirano, A., Handa, N., Hishikawa, S., Teratani, T., Kunita, S., Fukuda, J., et al. (2019). Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell-derived cardiomyocytes. J Heart Lung Transplant 38. 203\u2013214.","journal-title":"J Heart Lung Transplant"},{"key":"2801_CR183","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.oret.2019.04.021","volume":"3","author":"S Takagi","year":"2019","unstructured":"Takagi, S., Mandai, M., Gocho, K., Hirami, Y., Yamamoto, M., Fujihara, M., Sugita, S., Kurimoto, Y., and Takahashi, M. (2019). Evaluation of transplanted autologous induced pluripotent stem cell-derived retinal pigment epithelium in exudative age-related macular degeneration. Ophthalmol Retina 3. 850\u2013859.","journal-title":"Ophthalmol Retina"},{"key":"2801_CR184","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.7150\/thno.56757","volume":"11","author":"SH Tan","year":"2021","unstructured":"Tan, S.H., Loo, S.J., Gao, Y., Tao, Z.H., Su, L.P., Wang, C.X., Zhang, S.L., Mu, Y.H., Cui, Y.H., Abdurrachim, D., et al. (2021). Thymosin \u03b24 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction. Theranostics 11. 7879\u20137895.","journal-title":"Theranostics"},{"key":"2801_CR185","doi-asserted-by":"publisher","first-page":"eadf2898","DOI":"10.1126\/sciadv.adf2898","volume":"9","author":"Y Tan","year":"2023","unstructured":"Tan, Y., Coyle, R.C., Barrs, R.W., Silver, S.E., Li, M., Richards, D.J., Lin, Y., Jiang, Y., Wang, H., Menick, D.R., et al. (2023). Nanowired human cardiac organoid transplantation enables highly efficient and effective recovery of infarcted hearts. Sci Adv 9. eadf2898.","journal-title":"Sci Adv"},{"key":"2801_CR186","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/cvr\/cvaa215","volume":"117","author":"Z Tao","year":"2021","unstructured":"Tao, Z., Loo, S., Su, L., Tan, S., Tee, G., Gan, S.U., Zhang, J., Chen, X., and Ye, L. (2021). Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction. Cardiovasc Res 117. 1578\u20131591.","journal-title":"Cardiovasc Res"},{"key":"2801_CR187","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","volume":"11","author":"CJ Taylor","year":"2012","unstructured":"Taylor, C.J., Peacock, S., Chaudhry, A.N., Bradley, J.A., and Bolton, E.M. (2012). Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell 11. 147\u2013152.","journal-title":"Cell Stem Cell"},{"key":"2801_CR188","doi-asserted-by":"publisher","first-page":"103138","DOI":"10.1016\/j.scr.2023.103138","volume":"71","author":"N Thongsin","year":"2023","unstructured":"Thongsin, N., Suwanpitak, S., and Wattanapanitch, M. (2023). CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2). Stem Cell Res 71. 103138.","journal-title":"Stem Cell Res"},{"key":"2801_CR189","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.stemcr.2017.08.025","volume":"9","author":"S Tohyama","year":"2017","unstructured":"Tohyama, S., Fujita, J., Fujita, C., Yamaguchi, M., Kanaami, S., Ohno, R., Sakamoto, K., Kodama, M., Kurokawa, J., Kanazawa, H., et al. (2017). Efficient large-scale 2D culture system for human induced pluripotent stem cells and differentiated cardiomyocytes. Stem Cell Rep 9. 1406\u20131414.","journal-title":"Stem Cell Rep"},{"key":"2801_CR190","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","volume":"12","author":"S Tohyama","year":"2013","unstructured":"Tohyama, S., Hattori, F., Sano, M., Hishiki, T., Nagahata, Y., Matsuura, T., Hashimoto, H., Suzuki, T., Yamashita, H., Satoh, Y., et al. (2013). Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12. 127\u2013137.","journal-title":"Cell Stem Cell"},{"key":"2801_CR191","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/ten.tea.2023.0052","volume":"29","author":"S Uto","year":"2023","unstructured":"Uto, S., Hikita, A., Mori, D., Sakamoto, T., Yano, F., Ohba, S., Saito, T., Takato, T., and Hoshi, K. (2023). Subcutaneously transplanted fresh cartilage in allogeneic and xenogeneic immunocompetent mouse. Tissue Eng Part A 29. 541\u2013556.","journal-title":"Tissue Eng Part A"},{"key":"2801_CR192","first-page":"3231","volume":"142","author":"CW van den Berg","year":"2015","unstructured":"van den Berg, C.W., Okawa, S., Chuva de Sousa Lopes, S.M., van Iperen, L., Passier, R., Braam, S.R., Tertoolen, L.G., del Sol, A., Davis, R.P., and Mummery, C.L. (2015). Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells. Development 142. 3231\u20133238.","journal-title":"Development"},{"key":"2801_CR193","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.stem.2023.04.011","volume":"30","author":"JJ Vandana","year":"2023","unstructured":"Vandana, J.J., Manrique, C., Lacko, L.A., and Chen, S. (2023). Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation. Cell Stem Cell 30. 571\u2013591.","journal-title":"Cell Stem Cell"},{"key":"2801_CR194","doi-asserted-by":"publisher","first-page":"120195","DOI":"10.1016\/j.biomaterials.2020.120195","volume":"256","author":"J Veldhuizen","year":"2020","unstructured":"Veldhuizen, J., Cutts, J., Brafman, D.A., Migrino, R.Q., and Nikkhah, M. (2020). Engineering anisotropic human stem cell-derived three-dimensional cardiac tissue on-a-chip. Biomaterials 256. 120195.","journal-title":"Biomaterials"},{"key":"2801_CR195","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41551-021-00730-z","volume":"5","author":"B Wang","year":"2021","unstructured":"Wang, B., Iriguchi, S., Waseda, M., Ueda, N., Ueda, T., Xu, H., Minagawa, A., Ishikawa, A., Yano, H., Ishi, T., et al. (2021a). Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells. Nat Biomed Eng 5. 429\u2013440.","journal-title":"Nat Biomed Eng"},{"key":"2801_CR196","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.5966\/sctm.2015-0049","volume":"4","author":"D Wang","year":"2015","unstructured":"Wang, D., Quan, Y., Yan, Q., Morales, J.E., and Wetsel, R.A. (2015). Targeted disruption of the \u03b2 2-microglobulin gene minimizes the immunogenicity of human embryonic stem cells. Stem Cells Transl Med 4. 1234\u20131245.","journal-title":"Stem Cells Transl Med"},{"key":"2801_CR197","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/scd.2019.0300","volume":"30","author":"F Wang","year":"2021","unstructured":"Wang, F., Chen, X., Li, J., Wang, D., Huang, H., Li, X., Bi, Z., Peng, Y., Zhang, X., Li, G., et al. (2021b). Dose-and time-dependent effects of human mesenchymal stromal cell infusion on cardiac allograft rejection in mice. Stem Cells Dev 30. 203\u2013213.","journal-title":"Stem Cells Dev"},{"key":"2801_CR198","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.trim.2014.06.005","volume":"31","author":"H Wang","year":"2014","unstructured":"Wang, H., Qi, F., Dai, X., Tian, W., Liu, T., Han, H., Zhang, B., Li, H., Zhang, Z., and Du, C. (2014). Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin. Transplant Immunol 31. 65\u201374.","journal-title":"Transplant Immunol"},{"key":"2801_CR199","doi-asserted-by":"publisher","first-page":"eaba7606","DOI":"10.1126\/sciadv.aba7606","volume":"6","author":"K Wang","year":"2020","unstructured":"Wang, K., Lin, R.Z., Hong, X., Ng, A.H., Lee, C.N., Neumeyer, J., Wang, G., Wang, X., Ma, M., Pu, W.T., et al. (2020a). Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA. Sci Adv 6. eaba7606.","journal-title":"Sci Adv"},{"key":"2801_CR200","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41551-021-00796-9","volume":"5","author":"L Wang","year":"2021","unstructured":"Wang, L., Liu, Y., Ye, G., He, Y., Li, B., Guan, Y., Gong, B., Mequanint, K., Xing, M.M. Q., and Qiu, X. (2021c). Injectable and conductive cardiac patches repair infarcted myocardium in rats and minipigs. Nat Biomed Eng 5. 1157\u20131173.","journal-title":"Nat Biomed Eng"},{"key":"2801_CR201","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11427-019-1575-x","volume":"64","author":"Q Wang","year":"2021","unstructured":"Wang, Q., He, X., Wang, B., Pan, J., Shi, C., Li, J., Wang, L., Zhao, Y., Dai, J., and Wang, D. (2021d). Injectable collagen scaffold promotes swine myocardial infarction recovery by long-term local retention of transplanted human umbilical cord mesenchymal stem cells. Sci China Life Sci 64. 269\u2013281.","journal-title":"Sci China Life Sci"},{"key":"2801_CR202","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13287-020-01847-9","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang, X., Lu, M., Tian, X., Ren, Y., Li, Y., Xiang, M., and Chen, S. (2020b). Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey. Stem Cell Res Ther 11. 334.","journal-title":"Stem Cell Res Ther"},{"key":"2801_CR203","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jchf.2017.10.009","volume":"5","author":"BN Weber","year":"2017","unstructured":"Weber, B.N., Kobashigawa, J.A., and Givertz, M.M. (2017). Evolving areas in heart transplantation. JACC Heart Fail 5. 869\u2013878.","journal-title":"JACC Heart Fail"},{"key":"2801_CR204","doi-asserted-by":"publisher","first-page":"363ra148","DOI":"10.1126\/scitranslmed.aaf8781","volume":"8","author":"F Weinberger","year":"2016","unstructured":"Weinberger, F., Breckwoldt, K., Pecha, S., Kelly, A., Geertz, B., Starbatty, J., Yorgan, T., Cheng, K.H., Lessmann, K., Stolen, T., et al. (2016). Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Sci Transl Med 8. 363ra148.","journal-title":"Sci Transl Med"},{"key":"2801_CR205","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.5966\/sctm.2015-0044","volume":"4","author":"JS Wendel","year":"2015","unstructured":"Wendel, J.S., Ye, L., Tao, R., Zhang, J., Zhang, J., Kamp, T.J., and Tranquillo, R.T. (2015). Functional effects of a tissue-engineered cardiac patch from human induced pluripotent stem cell-derived cardiomyocytes in a rat infarct model. Stem Cells Transl Med 4. 1324\u20131332.","journal-title":"Stem Cells Transl Med"},{"key":"2801_CR206","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s11427-023-2419-9","volume":"67","author":"B Wu","year":"2024","unstructured":"Wu, B., Wang, Y., Yan, J., Liu, M., Li, X., Tang, F., and Bao, S. (2024). Blastoids generated purely from embryonic stem cells both in mice and humans. Sci China Life Sci 67. 418\u2013420.","journal-title":"Sci China Life Sci"},{"key":"2801_CR207","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00125-011-2433-9","volume":"55","author":"DM Xu","year":"2012","unstructured":"Xu, D.M., Yu, X.F., Zhang, D., Zhang, M.X., Zhou, J.F., Tan, P.H., and Ding, Y.C. (2012). Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice. Diabetologia 55. 1091\u20131102.","journal-title":"Diabetologia"},{"key":"2801_CR208","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M., Nomura, M., et al. (2019). Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24. 566\u2013578.e7.","journal-title":"Cell Stem Cell"},{"key":"2801_CR209","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/stem.166","volume":"27","author":"XQ Xu","year":"2009","unstructured":"Xu, X.Q., Soo, S.Y., Sun, W., and Zweigerdt, R. (2009). Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. Stem Cells 27. 2163\u20132174.","journal-title":"Stem Cells"},{"key":"2801_CR210","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka, S. (2020). Pluripotent stem cell-based cell therapy\u2014promise and challenges. Cell Stem Cell 27. 523\u2013531.","journal-title":"Cell Stem Cell"},{"key":"2801_CR211","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/CIRCRESAHA.114.300558","volume":"114","author":"X Yang","year":"2014","unstructured":"Yang, X., Pabon, L., and Murry, C.E. (2014). Engineering adolescence. Circ Res 114. 511\u2013523.","journal-title":"Circ Res"},{"key":"2801_CR212","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","volume":"15","author":"L Ye","year":"2014","unstructured":"Ye, L., Chang, Y.H., Xiong, Q., Zhang, P., Zhang, L., Somasundaram, P., Lepley, M., Swingen, C., Su, L., Wendel, J.S., et al. (2014). Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15. 750\u2013761.","journal-title":"Cell Stem Cell"},{"key":"2801_CR213","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1038\/s41598-020-58126-z","volume":"10","author":"S Yoshida","year":"2020","unstructured":"Yoshida, S., Miyagawa, S., Toyofuku, T., Fukushima, S., Kawamura, T., Kawamura, A., Kashiyama, N., Nakamura, Y., Toda, K., and Sawa, Y. (2020). Syngeneic mesenchymal stem cells reduce immune rejection after induced pluripotent stem cell-derived allogeneic cardiomyocyte transplantation. Sci Rep 10. 4593.","journal-title":"Sci Rep"},{"key":"2801_CR214","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1038\/s41598-019-45684-0","volume":"9","author":"JK Yu","year":"2019","unstructured":"Yu, J.K., Franceschi, W., Huang, Q., Pashakhanloo, F., Boyle, P.M., and Trayanova, N. A. (2019). A comprehensive, multiscale framework for evaluation of arrhythmias arising from cell therapy in the whole post-myocardial infarcted heart. Sci Rep 9. 9238.","journal-title":"Sci Rep"},{"key":"2801_CR215","doi-asserted-by":"publisher","first-page":"e056264","DOI":"10.1136\/bmjopen-2021-056264","volume":"12","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Xue, Y., Pan, T., Zhu, X., Chong, H., Xu, C., Fan, F., Cao, H., Zhang, B., Pan, J., et al. (2022). Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I\/IIa dose-escalation clinical trial. BMJ Open 12. e056264.","journal-title":"BMJ Open"},{"key":"2801_CR216","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/CIRCRESAHA.118.311213","volume":"123","author":"J Zhang","year":"2018","unstructured":"Zhang, J., Zhu, W., Radisic, M., and Vunjak-Novakovic, G. (2018). Can we engineer a human cardiac patch for therapy? Circ Res 123. 244\u2013265.","journal-title":"Circ Res"},{"key":"2801_CR217","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-023-2675-2","volume-title":"Sci China Life Sci","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z., Huang, W., Zhang, X., Wang, Z., Xie, M., Xie, B., Wang, Y., Chen, X., Xiang, A.P., and Xiang, Q. (2024). Human iPSC-derived mesenchymal stem cells relieve high blood pressure in spontaneously hypertensive rats via splenic nerve activated choline acetyltransferase-positive cells. Sci China Life Sci doi: https:\/\/doi.org\/10.1007\/s11427-023-2675-2."},{"key":"2801_CR218","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/CIRCULATIONAHA.120.049497","volume":"144","author":"M Zhao","year":"2021","unstructured":"Zhao, M., Nakada, Y., Wei, Y., Bian, W., Chu, Y., Borovjagin, A.V., Xie, M., Zhu, W., Nguyen, T., Zhou, Y., et al. (2021). Cyclin D2 overexpression enhances the efficacy of human induced pluripotent stem cell-derived cardiomyocytes for myocardial repair in a swine model of myocardial infarction. Circulation 144. 210\u2013228.","journal-title":"Circulation"},{"key":"2801_CR219","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7150\/ijbs.64640","volume":"18","author":"D Zheng","year":"2022","unstructured":"Zheng, D., Wang, X., Zhang, Z., Li, E., Yeung, C., Borkar, R., Qin, G., Wu, Y., and Xu, R.H. (2022). Engineering of human mesenchymal stem cells resistant to multiple natural killer subtypes. Int J Biol Sci 18. 426\u2013440.","journal-title":"Int J Biol Sci"},{"key":"2801_CR220","first-page":"229","volume-title":"Methods and Protocols. Methods in Molecular Biology","author":"WZ Zhu","year":"2014","unstructured":"Zhu, W.Z., Filice, D., Palpant, N.J., and Laflamme, M.A. (2014). Cardiac Tissue Engineering. In: Methods and Protocols. Methods in Molecular Biology. New York: Humana New York. 229\u2013247."}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-024-2801-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:07:43Z","timestamp":1756897663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-024-2801-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":220,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2801"],"URL":"https:\/\/doi.org\/10.1007\/s11427-024-2801-x","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. All figures in the text are generated using biorender.com.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}